BD 276909 - RPR Card Test Liquid Control Reagent, Diagnostic Use, EACH

BD 276909 - RPR Card Test Liquid Control Reagent, Diagnostic Use, EACH

The BD 276909 RPR Card Test Liquid Control Reagent is a diagnostic-quality control solution designed for use with Rapid Plasma Reagin (RPR) card tests. This liquid control supports verification of test performance by helping laboratories confirm proper reagent reactivity, procedural accuracy, and result interpretation during routine syphilis screening workflows. Manufactured to the quality standards of BD, the control reagent contributes to consistent, reliable serologic testing outcomes.

Intended for in vitro diagnostic use, this control is an essential component of laboratory quality assurance programs supporting non-treponemal syphilis testing.

Key Benefits

The liquid control reagent supports routine quality control checks to verify RPR card test performance. Consistent reactivity helps laboratories identify procedural or reagent-related issues before patient testing. Ready-to-use formulation simplifies workflow and reduces preparation time. Reliable quality control supports confidence in screening results and compliance with laboratory standards.

Compatibility and Applications

This control reagent is compatible with RPR card test methods commonly used in clinical and public health laboratories. It is widely utilized in hospital laboratories, reference labs, public health facilities, and diagnostic testing centers. Typical applications include daily or batch quality control verification for RPR screening assays.

Usage Guidelines

The reagent is intended for use by trained laboratory professionals. Before use, inspect the container for integrity and verify storage conditions. Perform quality control testing according to the RPR test procedure and laboratory protocol. Results should be evaluated against established acceptance criteria. Do not use beyond the labeled expiration date.

Certifications, Safety Standards, and Regulatory Approvals

The BD 276909 control reagent is manufactured under FDA-regulated quality systems applicable to in vitro diagnostic products. These controls support consistency, traceability, and reliability required for regulated laboratory testing environments.

Comparison with Competitor Products

Compared with non-standard or in-house controls, manufacturer-qualified RPR controls provide greater consistency and confidence in assay verification. While alternative control reagents may be available, BD diagnostic controls are widely trusted for dependable performance and alignment with validated testing methods.

Typical User Profile and Application Scenarios

This product is commonly used by medical laboratory scientists, clinical technologists, and public health laboratory personnel. It is particularly relevant in settings conducting routine syphilis screening where consistent quality control is essential for accurate diagnosis and reporting.

Best Practices for Use and Maintenance

Store the reagent under recommended conditions and protect it from contamination. Mix gently if required by protocol and avoid repeated freeze-thaw cycles if applicable. Document all quality control results in accordance with laboratory quality management procedures.

Regulatory and Safety Information

This diagnostic control reagent is intended for in vitro diagnostic use only. It meets applicable FDA medical device regulations for laboratory reagents. Proper handling, storage, and documentation are necessary to maintain regulatory compliance and test integrity.

How to Order

Ordering the BD 276909 RPR Card Test Liquid Control Reagent is straightforward. Add the product to your cart and proceed through the secure checkout process. For bulk laboratory purchasing, standing orders, or additional assistance, contact CIA Medical customer service at (312) 275-5850 or use the contact form available on this page.